treprostinil amomed 1 mg/ml raztopina za infundiranje
treprostinil - raztopina za infundiranje - treprostinil 1 mg / 1 ml - treprostinil
treprostinil amomed 10 mg/ml raztopina za infundiranje
treprostinil - raztopina za infundiranje - treprostinil 10 mg / 1 ml - treprostinil
treprostinil amomed 2,5 mg/ml raztopina za infundiranje
treprostinil - raztopina za infundiranje - treprostinil 2,5 mg / 1 ml - treprostinil
treprostinil amomed 5 mg/ml raztopina za infundiranje
treprostinil - raztopina za infundiranje - treprostinil 5 mg / 1 ml - treprostinil
zeposia
bristol-myers squibb pharma eeig - ozanimod hidroklorid - multiple sclerosis, relapsing-remitting; colitis, ulcerative - imunosupresivi - multiple sclerosiszeposia is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis (rrms) with active disease as defined by clinical or imaging features. ulcerative colitiszeposia is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis (uc) who have had an inadequate response, lost response, or were intolerant to either conventional therapy or a biologic agent.
emtricitabin/dizoproksiltenofovirat accordpharma 200 mg/245 mg filmsko obložene tablete
emtricitabin; tenofovir - filmsko obložena tableta - emtricitabin 200 mg / 1 tableta tenofovir136 mg / 1 tableta; tenofovir 136 mg / 1 tableta - dizoproksiltenofovirat in emtricitabin
baklofen sintetica 0,05 mg/ml raztopina za injiciranje
baklofen - raztopina za injiciranje - baklofen 0,05 mg / 1 ml - baklofen
baklofen sintetica 0,05 mg/ml raztopina za injiciranje
baklofen - raztopina za injiciranje - baklofen 0,05 mg / 1 ml - baklofen
baklofen sintetica 2 mg/ml raztopina za infundiranje
baklofen - raztopina za injiciranje - baklofen 2 mg / 1 ml - baklofen
baklofen sintetica 2 mg/ml raztopina za infundiranje
baklofen - raztopina za injiciranje - baklofen 2 mg / 1 ml - baklofen